Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute ... - BioSpace

Retrieved on: 2024-01-16 21:13:59

Tags for this article:

Click the tags to see associated articles and topics

Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute ... - BioSpace. View article details on hiswai:

Excerpt

Liège, Belgium – 16 January 2024, 07:30PM CET – Non-Regulated information - Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma ...

Article found on: www.biospace.com

View Original Article